Meeting Record Regarding: Use of Ozone Depleting Substances Removal of Essential Use Designation
Date: 5/11/2004
| Name |
Affiliation |
Client (if applicable) |
| Fumie Yokota |
OMB |
|
| Matthew Vaeth |
OMB/Health Division |
|
| Loren Monroe |
Barbour Griffith & Rogers, Inc. |
GlaxoSmithKline |
| Sally Walsh |
GlaxoSmithKline |
|
| Emily Bishko |
National Economic Research Associates, Inc. |
|
| Richard Rozek |
National Economic Research Associates, Inc. |
|
| Dominic Mancini |
OMB |
|
| Brenda Aguilar |
OMB |
|
| John Morrall |
OMB |
|
| Don Arbuckle |
OMB |
|
| Robert Meyer |
FDA (by phone) |
|
| Wayne Mitchell |
FDA (by phone) |
|
|
|
